THE CONTROVERSIAL ROLE OF BROMOCRIPTINE IN PARKINSONS-DISEASE

被引：9

作者：

HARDIE, RJ

LEES, AJ

STERN, GM

机构：

来源：

CLINICAL NEUROPHARMACOLOGY | 1985年 / 8卷 / 02期

关键词：

D O I：

10.1097/00002826-198506000-00004

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：150 / 155

页数：6

共 29 条

[21] BROMOCRIPTINE IN PARKINSONISM - LONG-TERM TREATMENT, DOSE-RESPONSE, AND COMPARISON WITH LEVODOPA [J].

PARKES, JD ;

DEBONO, AG ;

MARSDEN, CD .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1976, 39 (11) :1101-1108

[22] SHOULD DOPAMINE AGONISTS BE GIVEN EARLY OR LATE IN THE TREATMENT OF PARKINSONS-DISEASE [J].

RASCOL, A ;

MONTASTRUC, JL ;

RASCOL, O .

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :229-232

[23] METABOLITE INVOLVEMENT IN BROMOCRIPTINE-INDUCED CIRCLING BEHAVIOR IN RODENTS [J].

REAVILL, C ;

JENNER, P ;

MARSDEN, CD .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (04) :278-284

[24] BROMOCRIPTIN IN THE TREATMENT OF PROGRESSIVE STAGES OF PARKINSONS-DISEASE [J].

SCHNEIDER, E ;

FISCHER, PA .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 107 (05) :175-&

[25]

SEEMAN P, 1980, PHARMACOL REV, V32, P229

[26]

SHAW KM, 1980, Q J MED, V49, P283

[27] DIFFERENTIAL EFFECTS OF 3 DOPAMINE AGONISTS - APOMORPHINE, BROMOCRIPTINE AND LERGOTRILE [J].

SILBERGELD, EK ;

PFEIFFER, RF .

JOURNAL OF NEUROCHEMISTRY, 1977, 28 (06) :1323-1326

[28] BROMOCRIPTINE - LOW-DOSE THERAPY IN PARKINSON DISEASE [J].

TEYCHENNE, PF ;

BERGSRUD, D ;

RACY, A ;

ELTON, RL ;

VERN, B .

NEUROLOGY, 1982, 32 (06) :577-583

[29]

Yahr MD., 1976, ADV PARKINSONISM, P435

← 1 2 3 →